NCI | Technology Transfer

Chimeric Antigen Receptors Containing Glypican 2 Binding Domains

Read more about Chimeric Antigen Receptors Containing Glypican 2 Binding Domains

China
202510075685.4
Filed on 2025-01-17

ANTI-KRAS-G12D T CELL RECEPTORS

Read more about ANTI-KRAS-G12D T CELL RECEPTORS

Japan
2025-036871
Filed on 2025-03-07

RADIOLABELED GLYPICAN-3 (GPC3)-SPECIFIC SINGLE DOMAIN ANTIBODY AND USE THEREOF AS AN IMAGING AGENT FOR DETECTION OF GPC3-POSITIVE TUMORS

Read more about RADIOLABELED GLYPICAN-3 (GPC3)-SPECIFIC SINGLE DOMAIN ANTIBODY AND USE THEREOF AS AN IMAGING AGENT FOR DETECTION OF GPC3-POSITIVE TUMORS

Patent Cooperation Treaty
PCT/US2025/021789
Filed on 2025-03-27

HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS

Read more about HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS

China
202510245856.3
Filed on 2025-03-04

BETA-CATENIN INHIBITORS AND DEGRADERS

Read more about BETA-CATENIN INHIBITORS AND DEGRADERS

US Application 63/742,947
Filed on 2025-01-08

Glypican 2 As A Cancer Marker And Therapeutic Target

Read more about Glypican 2 As A Cancer Marker And Therapeutic Target

Austria
16864859.0
Filed on 2018-05-18

TREATMENT OF CARDIOVASCULAR DISEASE WITH TEM8 ANTIBODIES

Read more about TREATMENT OF CARDIOVASCULAR DISEASE WITH TEM8 ANTIBODIES

Patent Cooperation Treaty
PCT/US2025/017061
Filed on 2025-02-24

Synergistic Interactions For Improved Cancer Treatment

Read more about Synergistic Interactions For Improved Cancer Treatment

European Patent
23768747.0
Filed on 2025-01-29

Synergistic Interactions For Improved Cancer Treatment

Read more about Synergistic Interactions For Improved Cancer Treatment

US Application 19/101,938
Filed on 2025-02-07

SINGLE DOMAIN ANTIBODIES TARGETING HPV E6/E7 ONCOGENIC PEPTIDE/MHC
COMPLEXES

Read more about SINGLE DOMAIN ANTIBODIES TARGETING HPV E6/E7 ONCOGENIC PEPTIDE/MHC COMPLEXES

US Application 19/107,498
Filed on 2025-02-27

Subscribe to NCI